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Abstract
Zinc plays a protective role in anti-atherosclerosis but the clear mechanism has not been proposed yet. In the present study, we evaluated whether
zinc modulates atherosclerotic markers, VACM-1 and ICAM-1 and cell viability both in endothelial cells in vitro and mouse aortic cell viability
ex vivo. In study 1, as in vitro model, endothelial EA.hy926 cells were treated with TNFα for 5 hours for inducing oxidative stress, and then
treated with Zn-adequacy (15 μM Zn) or Zn-deficiency (0 μM Zn) for 6 hours. Pro-atherosclerosis factors, VCAM-1 and ICAM-1 mRNA expression
and cell viability was measured. In study 2, as ex vivo model, mouse aorta ring was used. Mourse aorta was removed and cut in ring then, cultured
in a 96-well plate. Aortic ring was treated with various TNFα (0-30 mg/ml) and intracellular zinc chelator, N, N, N′, N′, -tetrakis (2-pyridylmethyl)
ethylenediamine (TPEN, 0-30 μM) for cellular zinc depletion for 2 days and then cell viability was measured. The results showed that in in vitro
study, Zn-adequate group induced more VCAM-1 & ICAM-1 mRNA expression than Zn-deficient group during 6-hour zinc treatment post-5 hour
TNF-α treatment, unexpectedly. These results might be cautiously interpreted that zinc would biologically induce the early expression of anti-oxidative
stress through the increased adhesion molecule expression for reducing atherosclerotic action, particularly under the present 6-hour zinc treatment.
In  ex vivo, mouse aortic ring cell viability was decreased as TNF-α and TPEN levels increased, which suggests that mouse aortic blood vessel
cell viability was decreased, when oxidative stress increases and cellular zinc level decreases. Taken together, it can be suggested that zinc may
have a protective role in anti-atherosclerosis by cell viability in endothelial cells and aorta tissue. Further study is needed to clarify how pro-atherosclerosis
molecule expression is modulated by zinc. 
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Introduction4)
Atherosclerosis is a chronic inflammatory disease of arterial 
blood vessels and the development of atherosclerosis is 
influenced by genetic, lifestyle and nutritional factors (Beattie 
& Kwun, 2004; Henriksen et al., 2008). At present time, 
atherosclerosis and its complications remain a major cause of 
morbidity and mortality worldwide. Cardiovascular and cerebro-
vascular diseases cause over 15 million deaths every year - one 
third of the global total and coronary heart disease and stroke 
accounts for 7.2 million and 4.6 million, respectively (Kharbanda 
& MacAllister, 2005). 
Initiation of an atherosclerotic lesion involves an endothelial 
cell pro-inflammatory state by the oxidative stress that recruits 
leukocytes and promotes their movement across the endothelium. 
These processes require endothelial expression of adhesion 
molecules such as vascular cell adhesion molecule-1 (VCAM-1), 
intercellular adhesion molecule-1 (ICAM-1) and E-selectin. 
Proinflammatory cytokines, such as TNF-a, IL-1b, IL-4, 
accelerate atherosclerosis by inducing adhesion molecules of 
endothelium, such as intercellular cell adhesion molecule-1 
(ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) 
(Zheng et al., 2008). ICAM-1 and VACM-1 are two members 
of the Ig-like supergene family of adhesion molecules that are 
normally expressed by endothelial cells (Papagianni et al., 2003) 
and also in the aortic cells (Desai et al., 2007). 
Several studies indicate that zinc is vital to vascular endothelial 
cell integrity and for preventing severe impairment of the 
endothelial barrier function (Beattie & Kwun, 2004; Clair et al., 
1995; Hennig et al., 1992; McClain et al.,1995), since the 
endothelial dysfunction is considered as a surrogate marker of 
vascular pathology leading to atherosclerosis (Minqin et al., 
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Fig. 1. The endothelial EA.hy926 cell morphology by Zn treatment at 6 hours. 
The cells were exposed to TNFα (10 ng/ml) for 5 hours and after then, the cells 
were treated with TPEN (5 or 10 µM) and either Zn-deficient (0 μM Zn as ZnCl2, 
Zn-) or Zn adequate (15 μM Zn as ZnCl2, Zn+) medium for 6 hours. ZnCl2 was 
used for making 10 mM Zn stock solution. A: Zn chelator 10 µM TPEN with Zn- 
(0 μM) or Zn+ (15 μM). B: Zn chelator 5 µM TPEN with Zn- (0 μM) or Zn+ (15 
μM). 
2007). It is also reported that zinc is inversely correlated with 
the atherosclerotic lesion formation (Ren et al., 2003), which may 
be through the anti-atherogenic properties by inhibiting activation 
of oxidative stress-responsive transcription factors that are 
activated during an inflammatory response in atherosclerosis 
(Watt  et al., 2006). Therefore, zinc can slow down the 
progression of atherosclerosis, perhaps through its anti-infla-
mmatory properties and its ability to suppress the proliferation 
of the smooth muscle cells adding to intimal thickening (Berger 
et al., 2004; Reiterer et al., 2004). Moreover, recently from the 
pooled microarray data, it is reported that genes involved in 
cellular zinc homeostatis are modulated in atherosclerotic patients 
under the state of treatment for decreasing cholesterol synthesis, 
which implies zinc involvement in atherosclerosis incidence 
(Costarelli  et al., 2008). 
In the present study, we evaluated whether zinc deficiency 
decreased the viability of endothelial cells and mouse aortic ring 
cell  ex vivo model. Also, gene expression of VCAM-1 and 
ICAM-1 in endothelial cells was assessed to evaluate zinc 
modulation of CAMs. The study results could imply the potential 
role of zinc for preventing atherosclerosis. 
Materials and Methods 
Reagents
Chemicals were obtained from Sigma (St Louis, MO), unless 
otherwise noted. Cell culture reagents (DMEM, penicillin, HAT, 
streptomycin and fetal bovine serum) were obtained from Gibco 
Laboratories (Grand Island, NY, USA). All consumables and 
plastic wares were used with trace element free products or were 
soaked in 10% nitric acid solution to prevent zinc and other trace 
element contamination.
Study 1: In vitro study (EA.hy926 cell line) 
Cell culture and zinc treatment
The human endothelial cell line (EA.hy926; ATCC: CRL- 
2922) was originally derived from human umbilical vein and 
showed vascular endothelial cell characteristics. EA.hy926 cells 
were cultured in DMEM culture medium supplemented with 10% 
FBS, 2% HAT medium supplement (the final concentration of 
hypoxanthine, aminopterin, and thymidine was 100, 0.4 and 16 
mM, respectively) and 1% penicillin/streptomycin in a humi-
dified atmosphere of 5% CO2 at 37℃. The cells were treated 
just post-confluence because the differentiation marker for 
endothelial cell, von willebrand factor, was optimally expressed 
just post-confluence in this EA.hy926 cell line (Fig. 1 A-B). 
Cellular zinc was depleted using intracellular zinc chelator, N, 
N, N′, N′, -tetrakis (2-pyridylmethyl) ethylenediamine (TPEN). 
Just post-confluence, the cells were treated with either Zn- (0 
μM as ZnCl2) or Zn+ (15 μM as ZnCl2) with TPEN (5 or 10 
µM) for 6 hours. After then, the cells were exposed to TNFα 
(10 ng/ml) for 5 hours for inducing cellular oxidative stress. 
Stock ZnCl2 solution (10 mM) was prepared in appropriate 
concentration. The media were changed in every 2-3 days.
Cell morphology 
The cells were incubated with zinc, either in Zn- (0 µM) or 
Zn+ (15 µM) with two different levels of intracellular zinc 
chelator TPEN (5 or 10 µM TPEN) for 6 hours and then, were 
treated with TNF-α  (10 ng/ml) for another 5 hours. The 
morphological features of EA.hy926 cell line were assessed by 
inverted light microscope (Leica DMIL, Leica Microsystems, 
WetZlar, Germany) to observe the bulk morphology for apoptosis 
for both at 5 μM and 10 μM TPEN treatment. 
Trypan blue test 
The cells were incubated with zinc either in Zn- (0 µM Zn 
+ 10 µM TPEN) or Zn+( 15µM Zn + 10 µM TPEN) for 6 hours 
and then, were treated with TNF-α (10 ng/ml) for another 5 hours. 
The cell viability of EA.hy926 cell was determined by the trypan 
blue exclusion assay, in which if the dead cell membrane is 
leaking and then dead cells uptake trypan blue dye while viable 
cells don’t. 
RT- PCR for von Willebrand factor and cellular adhesion 
molecules (VCAM-1 and ICAM-1) 
mRNA expression of von Willebrand factor as endothelial cell 
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Table 1. Primer base sequence for target and housekeeping genes
Genes Base sequences
von Willebrand factor
(vWF)
5′-CTGGGAGAAGAGGGTCACAG-3′ (Forward)
5′-TGGAGTACATGGCTTTGCTG-3′ (Reverse)
ICAM-1 5′-GGTGACGCTGAATGGGGTCC-3′ (Forward)
5′-TCCTCATGGTGGGGCTATGACTC-3′ (Reverse)
VCAM-1 5′-ATGCCTGGGAAGATGGTCGTGA-3′ (Forward)
5′-TGGAGCTGGTAGACCCTCGCTG-3 (Reverse)
β-actin 5′-ATCGTGGGGCGCCCCAGGCAC-3′ (Forward)
5′-CTCCTTAATGTCACGCACGATTTC-3′ (Reverse)
molecules (VCAM-1 and ICAM-1) was measured by RT-PCR. 
For RNA extraction from EA.hy926 cells, Trizol reagent 
(Invitrogen, USA) was used as commercial instruction. For the 
synthesis of first-strand cDNA, 100 ng of RNA from each sample 
were reverse transcribed using 20 U of AMV reverse transcriptase 
and oligo-p (dT) 1X random primers. The resulting cDNAs were 
PCR-amplified by using a mixture of the corresponding sense 
(forward) and antisense (reverse) primers (Table 1). Primers for 
target and housekeeping genes were obtained from Bioneer 
Corporation (Daedeok-gu, Daejeon 306-220, Korea). The PCR 
conditions were 95℃ for 2 min and then 36 cycles at 95℃ for 
30s, 55℃ for 45s and 70℃ for 1 min and a final extension at 
72℃  for 5 min. The PCR products were separated on 1.8% 
agarose gel. 
Study 2: Ex vivo study (mouse aortic ring culture study) 
Mouse aortic ring culture 
Mouse aorta from C57BL/6 strain was removed and all adipose 
tissues were removed. The aorta was dissected in three major 
parts through the entire aorta for random sampling and then, the 
aorta was dissected 0.5 mm in thickness for the aortic ring 
samples to culture in a culture dish, as ex vivo. Mouse aortic 
ring was cultured in a 96-well plate as one ring per well in 
DMEM culture medium supplemented with 30% FBS and 1% 
penicillin/streptomycin in a humidified atmosphere of 5% CO2 
at 37℃. The aortic ring culture was carefully examined overnight 
and cultured for another two to three days, until the aortic ring 
culture being confirmed viable. After confirming the aortic ring 
being viable, then MTT assay was done for evaluating aortic 
ring cell viability. 
MTT assay for viability of mouse aortic ring cells
Mouse aortic ring cell viability was determined by the MTT 
assay on the metabolic reduction of 3-[4, 5-dimethylthiazol- 
2-y]-2, 5-diphenyltetrazolium bromide (MTT). Aortic ring was 
plated in a 96-well plate and maintained in growth media for 
2-3 days at 5% CO2 at 37℃. After then, the aortic ring was 
treated with TNFα with the range of 0-30 ng/ml to evaluate aortic 
cell viability by oxidative stress or TPEN with the range of 0-30 
mM to evaluate if cellular zinc depletion by TPEN decreased 
aortic ring cell viability for 2 days. Ten micorliter of MTT 
solution was added in each well and incubated at 37℃ for 3 
hours to allow for the formation of formazan crystals. After 
formation of formazan crystals, the MTT medium was then 
aspirated and replaced with solubilization solution (DMSO) for 
dissolving the formazan crystals. The plates were read on Micro 
Elisa reader (Asys Hitee, Expert 96, Asys Co., Austria) at 570nm.
Results 
In vitro study 
Cell morphology 
The cells were shown to be less viable morphologically in zinc- 
and the viability was much less in higher Zinc chelator treatment 
group (10 μM TPEN), where less free zinc was available by 
cells than in lower Zinc chelator group (5 μM TPEN) (Fig. 1). 
The cells in Zn- showed fewer adherents to the cell dish and 
visually apoptotic. zinc deficiency decreased endothelial cell 
viability even within 6 hours, and the less viable morphology 
was observed in higher zinc chelator level at 10 μM TPEN.
Trypan blue test 
The cell viability was decreased by zinc deficiency (0 μM Zn) 
for 6 hours. Seventy five percent cell viability was observed at 
the Zn- (0 µM Zn + 10 µM TPEN), while Zn- (15 µM Zn + 
10 µM TPEN) showed 94% of cell viability of 6 hours zinc 
treatment, followed by 10 ng/ml TNFα  treatment (data not 
shown). 
mRNA expression for von Willebrand factor, VCAM-1 & ICAM-1
To confirm if this particular cell line was appropriate for testing 
endothelial characteristics, von Willebrand factor was assessed, 
since von Willebrand factor is related to the formation of clots 
and also can be a characteristic of endotherial cells. von 
Willebrand factor on endothelial cells was expressed from the 
just pre-confluence and was maximally from the post-confluence 
2 days and maintained up to 6 days (Fig. 2 A). Therefore, we 
decided to treat zinc just post-confluence on 2 days on this cell 
model. The cells were treated for 6 hours with the level of Zn 
– (1µM) and Zn+ (15 µM), and after then, the cells were exposed 
with TNFα for 5 hours. mRNA expression of adhesion molecules, 
VCAM-1 and ICAM-1, were measured by RT-PCR. The mRNA 
expression of VCAM-1 and ICAM-1 mRNA was higher in Zn+ 
than Zn-, unexpectedly, under this experimental condition. Even 
ICAM-1 mRNA expression showed a bit less discrepancy 
between Zn- and Zn+ (Fig. 2 B, data are presented as the repres-
entative of three replicates). For the atherosclerotic incidence, 
once inflammatory stimuli signal to the vascular endothelium, 
which then in turn mediates leukocyte recruitment and adherence 
to the endothelium at the early stages of vascular inflammation, Young-Eun Cho et al. 77
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Fig. 2. (A) Confirmation of von Willebrand factor gene expression in EA.hy926 
cells. Zero day means when the cells were at confluence. (B) Representative gene 
expression image of VCAM-1 and ICAM-1 of 6 hour zinc treatment in EA.hy 
926 cells. The cells were exposed to TNFα (10 ng/ml) for 5 hours and after then, 
the cells were treated with TPEN (5 or 10 µM) and either Zn- (0 μM) or Zn+ (15 
μM)  for  6  hours.  The  experiment  was  done  in  triplicate.
Table 2. MTT viability assay under different TNFα  concentration for mouse 
aorta cells at 2 days treatment
TNFα
(ng/ml)
Cell viability
% control
0 (control)
5
10
20
30
100.00 ± 18.2
a
  80.8 ± 27.3
ab
  78.4 ± 14.4
ab
  64.7 ± 35.2
b
  5.00 ± 5.7
c
D a t a  r e p r e s e n t  m e a n  ±  S E M  ( n = 8 ) ,  T u k e y ’ s  t e s t ,  A N O V A  a t  p< 0.05
Table 3. MTT viability assay under different TPEN concentration for mouse 
aorta cells at 2 days treatment
TPEN 
(µM)
Cell viability 
(% control)
0 (control)
5
10
20
30
100.0 ± 48.2
a
124.4 ± 4.5
a
 56.6 ± 5.7
b
  1.1 ± 3.6
c
 -1.7 ± -2.3
c
D a t a  r e p r e s e n t  m e a n  ±  S E M  ( n = 8 ) ,  T u k e y ’ s  t e s t ,  A N O V A  a t  p< 0.05
ultimately leading to the progression of numerous vascular 
diseases. VCAM-1 and ICAM-1 are responsible for the process 
of formation of endothelium adherence. 
Ex vivo study 
MTT viability for mouse aorta by TNFα & TPEN
The functional integrity of the aortic ring, under zinc 
deficiency, was assessed using the MTT viability assay for mouse 
aortic ring culture. At first, we evaluated if cell viability affected 
in this particular ex vivo mouse aortic ring culture sample which 
was treated by TNFα, the inducer of oxidative stress. The 
viability of mouse aorta cells was inversely proportional to the 
TNFα concentration (0-30 ng/mL, Table 2), which confirmed the 
TNFα-induced oxidative stress, and again which decreased mouse 
aortic ring viability. On considering the 0 ng/mL of TNFα is 
100 % cell viability, 10 ng/ml TNFα treatment showed marginal 
viability level (78.4%), and then we decided to treat with this 
level for consecutive zinc chelator experiment for mouse aortic 
ring viability by cellular zinc deficiency. Then, we evaluated 
whether less cellular zinc availability could decrease mouse aortic 
ring viability. Cellular zinc depletion was induced by increasing 
the addition of intracellular zinc chelator, TPEN (0-30 μM). The 
aortic ring cell viability showed that as the added TPEN level 
increased, which means less cellular zinc is available, the aortic 
ring cell viability was decreased as shown in Table 3. The results 
showed that as cellular zinc was less available, then aortic cell 
viability decreased. 
Discussion 
The present study evaluated the potential role of zinc on 
vascular disease induced by oxidative stress, in that whether 
cellular zinc deficiency decreased the viability of both the 
endothelial cell in EA.hy926 cell line and the mouse aortic cells 
ex vivo model. Also it was examined whether cellular zinc 
deficiency modulated the mRNA expression of VCAM-1 and 
ICAM-1 in endothelial cells. To confirm beforehand if this 
particular endothelial cell line, EA.hy926 cells, shows the 
appropriate condition for vascular and inflammatory morphology, 
von Willebrand factor (vWF) gene which is considered as the 
endothelial cell differentiation was measured and confirmed vWF 
gene expression in the cells under the present study condition. 
vWF mRNA was expressed from 0 to 6 days of EA.hy 926 cell 
culture after TNFα treatment. vWF is normally synthesized by 
the endothelial cells and stored in the Weibel-Palade bodies and 
it is secreted on endothelial activation (Collins et al., 1993). 
Normally, the increased plasma vWF levels are associated with 
cardiovascular disease (Theilmeier et al., 2008). 
In the present study, the results showed that zinc could protect 
endothelial cell viability both in endothelial in vitro and mouse 
aortic  ex vivo model under TNFα-induced oxidative stress 
condition, which causes cardiovascular abnormality such as 
atherosclerosis. TNFα  induce the inflammatory signal for 
increasing the oxidative stress and thus increase the cell apoptosis 
through stimulating the oxidative stress in endothelial cells (Ling 
et al., 2007). Ex vivo study showed that as more cellular zinc 
chelator TPEN was added, which means less cellular zinc is 
available, then the mouse aortic ring culture viability was 
decreased under TNFα treatment (Table 3). In vitro study results 
also showed as being consistent with the results of ex vivo, in 
which zinc deficiency (Zn-) followed by TNFα treatment showed 
more apoptotic and lower cell viability than zinc adequacy (Zn+) 
(Fig. 1 and trypan blue test results). 
In fact, it is reported that zinc deficiency induces cell death 
in various cellular models (Clegg et al., 2005), however, not 
much confirmed in endothelial cell models and nor in mouse 
aortic ring culture model, ex vivo. The endothelial cell model 
from porcine pulmonary arteries showed lower cell viability 78 Zinc deficiency decreases cell viability in endothelial cells and in mouse aorta ex vivo
under zinc deficiency induced by TPEN zinc chelator (Hennig 
et al., 1999; Meerarani et al., 2000). Therefore, the findings in 
the current study confirmed that zinc could protect cell death 
in human origin endothelial EA.hy926 cells, which has not been 
reported before, in addition to mouse aortic ring culture 
condition. The preventive role of zinc for the decreased cell 
viability in endothelial cells and mouse aortic tissue culture in 
the current study results can be interpreted that zinc can increase 
endothelial cell viability under oxidative stress, which can be 
protective for atherosclerosis in the endothelium of blood vessels. 
In our in vitro model, Zn- showed low cell viability than Zn+ 
in human origin endothelial EA.hy926 cells at 6-hour zinc 
treatment prior to TNFα treatment, which causes intracellular 
oxidative signal. Under TNFα exposure, the high cell viability 
in Zn+ might result from the anti-oxidative property of zinc, since 
zinc has an antioxidant role as a component of systemic 
antioxidant enzyme such as Cu/Zn-SOD (Formigari et al., 2007). 
The intracellular oxidative signals may provide a molecular 
mechanism linking the oxidative signal which is one of risk 
factors for the early pathogenesis of atherosclerosis through the 
expression of some vascular inflammatory genes, such as cell 
adhesion molecules VCAM-1 and ICAM-1 (Alexander et al., 
1995; Kunsch & Medford, 1999). It is reported that the cell 
adhesion molecules VCAM-1 and ICAM-1 are expressed in 
endothelial cells by oxidative stress, such as TNFa and other 
inflammatory molecules (Choi et al., 2004; Reiterer et al., 2004). 
In the present study, mRNA expression of VCAM-1 and ICAM-1 
under zinc treatment in EA.hy926 cells was evaluated and 
unexpectedly, VCAM-1 and ICAM-1 mRNA expression was 
highly expressed in Zn+ under the current experimental condition 
of 6-hour zinc treatment (1 μM or 15 μM) prior to TNFα 
exposure (10 ng/ml). The potential explanation of the current 
contradicting results for VCAM-1 and ICAM-1 mRNA 
expression might be due to shorter zinc treatment time period 
(6 hours with 1 or 15 μM Zn) and stronger TNFα exposure 
condition (10 ng/ml for 5 hours), compared to longer Zinc 
treatment (20 μM for 24 hours) and weaker TNFα exposure (10 
ng/L for 2 hours) (Reiterer et al., 2004). Further study for 
VACM-1 and ICAM-1 expression under optimal experimental 
condition would be needed for getting final conclusion. 
Normally, more endothelial adhesion molecules, VCAM-1 and 
ICAM-1, induce more oxidative stress, which may cause the 
progression of atherosclerosis. Even under the current particular 
experimental condition, a potential explanation for higher mRNA 
expression VCAM-1 and ICAM-1 in Zn+ would be suggested: 
One possibility would be that the VCAM-1 and ICAM-1 were 
up-regulators of atherosclerosis, which means these were 
expressed normally before the progression of atherosclerosis. In 
our study, Zn+ showed more VCAM-1 and ICAM-1 expression 
which biologically induces more expression of anti-oxidative 
enzymes. Recent study showed that  the antioxidant defense 
system against lipid peroxidation was increased, which can 
propose to retard the development of atherosclerosis. Also, the 
increase in Cu/Zn-superoxide dismutase (Cu/Zn-SOD) activity 
may reduce vascular cell-mediated oxidation of low-density 
lipoprotein in mouse aorta (Yang et al., 2004). 
Taken all together, zinc adequate can protect endothelial 
damage which is induced by oxidative stress through increasing 
endothelial cell viability and aortic ring culture cell viability. 
Also, zinc modulates cellular adhesion molecules (VDAM-1 and 
ICAM-1) mRNA expression in endothelial cells. These findings 
are cautiously interpreted that zinc can be a factor for preventing 
atherosclerosis incidence. Further investigation will undertake for 
clarifying the mechanism by zinc for anti-atherosclerosis.
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